Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Under-Reported Role of Toxic Substance Exposures in the Covid-19 Pandemic Publisher Pubmed



Kostoff RN1 ; Briggs MB2 ; Porter AL3, 4 ; Hernandez AF5 ; Abdollahi M6 ; Aschner M7, 8 ; Tsatsakis A8, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Affiliate, School of Public Policy, Georgia Institute of Technology, Gainesville, VA, United States
  2. 2. Roscommon, MI, United States
  3. 3. School of Public Policy, Georgia Institute of Technology, Atlanta, GA, United States
  4. 4. Search Technology, Peachtree Corners, GA, United States
  5. 5. Department of Legal Medicine and Toxicology, University of Granada School of Medicine, Health Sciences Technological Park, Granada, Spain
  6. 6. Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY, United States
  8. 8. IM Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
  9. 9. Laboratory of Toxicolgy and Forensic Sciences, Faculty of Medicine, University of Crete, Heraklion, 71003, Greece

Source: Food and Chemical Toxicology Published:2020


Abstract

Coronavirus disease 2019 (COVID-19) and previous pandemics have been viewed almost exclusively as virology problems, with toxicology problems mostly being ignored. This perspective is not supported by the evolution of COVID-19, where the impact of real-life exposures to multiple toxic stressors degrading the immune system is followed by the SARS-CoV-2 virus exploiting the degraded immune system to trigger a chain of events ultimately leading to COVID-19. This immune system degradation from multiple toxic stressors (chemical, physical, biological, psychosocial stressors) means that attribution of serious consequences from COVID-19 should be made to the virus-toxic stressors nexus, not to any of the nexus constituents in isolation. The leading toxic stressors (identified in this study as contributing to COVID-19) are pervasive, contributing to myriad chronic diseases as well as immune system degradation. They increase the likelihood for comorbidities and mortality associated with COVID-19. For the short-term, tactical/reactive virology-focused treatments are of higher priority than strategic/proactive toxicology-focused treatments, although both could be implemented in parallel to reinforce each other. However, for long-term pandemic prevention, toxicology-based approaches should be given higher priority than virology-based approaches. Since current COVID-19 treatments globally ignore the toxicology component almost completely, only limited benefits can be expected from these treatments. © 2020 Elsevier Ltd
Other Related Docs
12. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
20. Tocilizumab in Icu-Admitted Covid-19 Patients: A Retrospective Study, Medical Journal of the Islamic Republic of Iran (2023)
23. Pediatric Endocrinopathies Related to Covid-19: An Update, World Journal of Pediatrics (2023)
29. A Review of Antibiotic Efficacy in Covid-19 Control, Journal of Immunology Research (2023)
31. Cardiovascular Manifestations in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Cardiovascular and Thoracic Research (2021)
34. Association of Pesticide Exposure With Human Congenital Abnormalities, Toxicology and Applied Pharmacology (2018)
50. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)